Kalaris Therapeutics is a startup based in the United States.
Kalaris Therapeutics is a company headquartered in the United States.
Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for prevalent retinal diseases, including neovascular age-related macular degeneration, using engineered biologics to improve anti-VEGF treatment durability and patient outcomes.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.